Novel antitumoral use of cabazitaxel

• 收藏
• 分享

专利权人:

Aventis Pharma S.A.

发明人:

Sunil, Gupta

申请号：

AU2015200149

公开号：

AU2015200149A1

申请日:

2015.01.14

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

#$%^&*AU2015200149A120150226.pdf#####ABSTRACT The invention relates to a cabazitaxel, which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/